Partnering to Advance Drug Delivery Innovation

About this Webinar: 

In this webinar, business development and technology assessment professionals actively involved in the scouting and evaluating of novel delivery technologies, discuss the constantly evolving topic of partnering. They share: 


  • Strategic considerations in evaluating external drug delivery technologies 

  • Partnership pathways and approaches for companies at different stages of technology development

  • Common obstacles that can slow partnership conversations and advice on how to preempt them
  • The roles of procurement, business development and other functional groups in scoping, structuring deals and negotiation 

Key Takeaways: 

  • Partnership structures that have proven successful for early-stage delivery technologies 
  • How companies structure milestone payments and success metrics for delivery technology partnerships where clinical benefit may emerge gradually
  • Beyond the core technology dataadjacent capabilities or expertise in a startup significantly increase their attractiveness as a partner.
  • Technical red flags or gaps in early data packages that cause pharma to pass on otherwise interesting technologies. 

This webinar is a rebroadcast from the original presentation at the PODD Drug Delivery 2025 event and brought to you by popular demand.  

This webinar is brought to you by PODD®: 

Partnership Opportunities in Drug Delivery (PODD®) is committed to upholding its tradition of combining partnering, access to cutting-edge business and scientific content in the field of drug delivery, with loyal support from a top-notch speaking faculty. Pharma, biotech and the drug delivery industries gather annually at PODD to assess delivery needs, latest trends and information on deals and learn about a wide range of innovative drug delivery technologies that could improve the delivery of various types of drugs. This can include proteins, peptides, oligonucleotides, biologics, and small molecules and more. PODD provides business development opportunities through organized networking and a partnering tool for new, emerging and established collaborations. 


The PODD 2026 Conference is scheduled for October 29-30 at The Sheraton Boston. 

 

Moderators
Ester Caffarel-Salvador, PhD
Director, Strategic Innovation
Chiesi USA
Panelists
Annette Bak, PhD, MBA
Head of Advanced Drug Delivery
AstraZeneca
Sean Bedingfield, PhD
Director - Genetic Medicine
Eli Lilly and Company
Jaymin Shah, PhD
Senior Research Fellow and Head of Biopharmaceutics
Pfizer
Rashmi Thakur
Director, Portfolio Strategy & Integration
Bristol Myers Squibb
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.